Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Richard Simon, NCI’s visionary biostatistician, dies at 80
Obituary

Richard Simon, NCI’s visionary biostatistician, dies at 80

May 24, 2024
Vol.50 No.21
By Paul Goldberg
As House prepares cuts for NIH, Rathmell urges Senate to protect funding in FY25
Capitol Hill

As House prepares cuts for NIH, Rathmell urges Senate to protect funding in FY25

May 24, 2024
Vol.50 No.21
By McKenzie Prillaman
NCI: Cancer center communicators are key to the success of the National Cancer Plan

NCI: Cancer center communicators are key to the success of the National Cancer Plan

May 24, 2024
Vol.50 No.21
By Jacquelyn Cobb
Single-cell based precision oncology: First steps in addressing and overcoming tumor heterogeneity
Trials & Tribulations

Single-cell based precision oncology: First steps in addressing and overcoming tumor heterogeneity

May 10, 2024
Vol.50 No.19
By Sanju Sinha and Eytan Ruppin
In Brief

NCI renews MUSC Hollings support grant with “outstanding” rating

April 19, 2024
Vol.50 No.16
Pooled analysis questions reliability of an endpoint used in multi-cancer detection trials

Pooled analysis questions reliability of an endpoint used in multi-cancer detection trials

April 12, 2024
Vol.50 No.15
By Jacquelyn Cobb
Rathmell: To improve funding outlook, we must reverse distrust in science
NCI

Rathmell: To improve funding outlook, we must reverse distrust in science

April 12, 2024
Vol.50 No.15
By Matthew Bin Han Ong
NCI creates Cancer Equity Leaders group to improve cancer health equity
Health Equity

NCI creates Cancer Equity Leaders group to improve cancer health equity

April 12, 2024
Vol.50 No.15
By Matthew Bin Han Ong
NCI maintains paylines for early-stage investigators, cuts funding for other R01s and noncompeting grants in FY24

NCI maintains paylines for early-stage investigators, cuts funding for other R01s and noncompeting grants in FY24

April 05, 2024
Vol.50 No.14
By Matthew Bin Han Ong
In Brief

NCI renews UChicago’s CCC designation

April 05, 2024
Vol.50 No.14

Posts navigation

Previous1…171819…39Next

Trending Stories

  • As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
    The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded
  • Peter F. Garrett to people with cancer: Your story has power
  • OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
  • Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
    “The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
  • What NHS-Galleri taught us—and what it didn’t
  • The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account